D

DreamCIS Inc
KOSDAQ:223250

Watchlist Manager
DreamCIS Inc
KOSDAQ:223250
Watchlist
Price: 6 000 KRW -8.26% Market Closed
Market Cap: 142.8B KRW

DreamCIS Inc
Investor Relations

DreamCIS, Inc. operates as clinical trial agency which engages in the provision of clinical online information and consultation services. The company is headquartered in Seoul, Seoul. The company went IPO on 2020-05-22. The firm mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The firm provides its services within domestic market and to overseas markets.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Youngil Lee
Executive Director
No Bio Available
Ms. Jiwon Son
Head of Clinical Research & Executive Director
No Bio Available

Contacts

Address
SEOUL
Seoul
10F, Jeokseon-Hyundai Bldg., 130, Sajik-ro, Jongno-gu
Contacts
+82220104500
www.dreamcis.com